Disparities in the care and direct-acting oral anticoagulant (DOAC) management in atrial fibrillation (AF) and chronic kidney disease (CKD) in English primary care between 2018 and 2022: primary care sentinel network database study.

ABSTRACT:

Background

In England, most prescribing of direct-acting oral anticoagulants (DOACs) for patients with chronic kidney disease (CKD) and atrial fibrillation (AF) takes place in primary care. The 2024 European Society of Cardiology guidelines introduced the AF-CARE ((C) comorbidities and risk factors; (A) avoid stroke and thromboembolism by appropriate prescription of oral anticoagulants; (R) rate and rhythm control; (E) evaluation and reassessment should be individualised for every patient, with a dynamic approach) framework to address this.

Objective

To describe any health disparities in CKD and AF, including anticoagulation management and correct dosing of DOACs.

Methods

Using English primary care sentinel network data from 2018 to 2022, demographics of AF and CKD in

SUBMITTER: Emanuel S 

PROVIDER: S-EPMC12096997 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature